We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Owlstone Medical’s Breath Biopsy Platform Integrated into GSK’s Clinical Trial

News   Nov 27, 2017

 
Owlstone Medical’s Breath Biopsy Platform Integrated into GSK’s Clinical Trial
 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine Trial Revived by WHO as Doubt Cast on Lancet, NEJM Studies

News

Testing of the malaria drug hydroxychloroquine as a treatment for COVID-19 has been restarted by the WHO after researchers raised concerns about the paper, published in The Lancet two weeks ago, that first suggested the drug was linked to reduced survival and a higher risk of heart-related side effects.

READ MORE

Researchers Develop New Way To Detect Blood Clots

News

Researchers in the Department of Biomedical Engineering at Texas A&M University are working on an entirely new way to detect blood clots, especially in pediatric patients.

READ MORE

Clinical Trials in an Era of Digital Engagement

News

Researchers from SWOG Cancer Research Network pose provocative questions aimed at sparking discussion and creating consensus on how cancer clinical trial stakeholders can best interact on social platforms.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE